Telfastin Allergo

Quick links

Choose a section

Quick links to important sections

Advertisements

Telfastin Allergo

Advertisements
Advertisements

Treatment option: Hives, Rhinitis, Hay Fever

Advertisements

Overview of Telfastin Allergo

Quick Facts

Property Description
Active Ingredient Fexofenadine hydrochloride
Form Film-coated tablet
Pharmacological Class Second-generation antihistamine
General Purpose Symptomatic relief of allergic discomfort
Origin Synthetic compound

What Type of Medicine is Telfastin Allergo?

Telfastin Allergo is a medicinal preparation whose core identity is defined by its active ingredient, Fexofenadine. It is classified within the therapeutic category of antihistamines, specifically as a second-generation H1-receptor antagonist. This pharmacological classification signifies that the preparation is a synthetic compound designed to selectively target receptors associated with allergic responses. The medicine is supplied as an oral formulation in the physical form of a film-coated tablet. Its consistent action is clinically recognized for addressing discomfort without causing the central nervous system impairment often associated with older allergy medications, a key feature in its positioning for use during daytime activities.


Fexofenadine: The Composition and General Purpose

The activity of the product originates entirely from a single component, Fexofenadine hydrochloride, establishing it as a single-ingredient product (monopreparation). The drug's general purpose is to provide highly effective relief from the most common and disruptive physical manifestations of allergic reactions. Its mechanism principle involves blocking the effects of the natural chemical histamine, which the body releases during an allergic episode. Fexofenadine is recognized for its non-sedating nature. By acting as a highly selective histamine blocker, Telfastin Allergo helps mitigate symptoms such as sneezing, watery eyes, and itching associated with conditions like allergic rhinitis and chronic idiopathic urticaria.

Regulatory References

  1. Fexofenadine: MedlinePlus Drug Information
Advertisements

What side effects are possible with Telfastin Allergo?

Official Adverse Reactions and Safety Profile

The safety profile for Telfastin Allergo (Fexofenadine hydrochloride) is officially documented by government regulatory authorities based on clinical trials and post-marketing surveillance. Adverse reactions are formally grouped by the frequency of their occurrence and the physiological system they affect.


Frequency-Classified Effects

The majority of reported adverse reactions are generally classified as Common or Uncommon, affecting the Nervous and Gastrointestinal Systems. The regulatory labeling outlines the following primary categories:

Classification Examples of Effects System-Organ Class
Common (ge 1/100) Headache, Drowsiness, Nausea, Dizziness Nervous System, Gastrointestinal
Uncommon (ge 1/1,000) Fatigue, Insomnia General, Nervous System

Serious Adverse Reactions

Rare, clinically significant events are documented through post-marketing experience. These serious reactions are classified as Rare or Frequency Not Known and include manifestations of severe hypersensitivity reactions such as Anaphylaxis, Angioedema (swelling of the face or throat), Dyspnea (difficulty breathing), and Urticaria (hives).


Safety Considerations and Restrictions

The regulatory profile specifies safety considerations related to the drug's elimination and absorption. Caution is required in patients with impaired renal function because the drug is primarily eliminated by the kidneys, which may lead to increased systemic exposure. The label also documents that simultaneous consumption of fruit juices (e.g., grapefruit, orange, apple) and co-administration with aluminum and magnesium-containing antacids can reduce the absorption of fexofenadine, altering the intended drug exposure. Co-administration with certain medications, such as erythromycin or ketoconazole, is noted to increase plasma concentrations of fexofenadine, potentially increasing the risk of adverse reactions.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Fexofenadine hydrochloride overdose defines the specific manifestations and the mandatory emergency actions required. The maximum tolerated dose of the substance has not been established in human subjects, and regulatory authorities formally state that taking more than directed can cause serious health problems.

Documented Clinical Manifestations

Symptoms and signs officially reported in association with excessive intake include:

  • Dizziness
  • Drowsiness
  • Dry mouth
  • Fatigue

Mandatory Emergency Response

In the event of a suspected or confirmed overdose, official documents mandate immediate action. You must seek medical help or contact a Poison Control Center right away due to the potential severity of the effects.


Official Management Principles

Management guidance is centered on symptomatic and supportive treatment because no specific antidote is known to be available. Regulatory documents recommend that standard measures should be considered to remove any unabsorbed medicinal product. A specific procedural constraint noted is that haemodialysis does not effectively remove fexofenadine hydrochloride from the blood. The overall regulatory profile strictly focuses on the necessary immediate response and supportive care.

Advertisements

Therapeutic Uses of Telfastin Allergo

What Telfastin Allergo Treats: Main Uses and Benefits

Telfastin Allergo is relevant for easing symptoms across key allergic domains. The medication is commonly used for managing conditions characterized by periods of heightened symptoms in both the respiratory tract and skin. It is applied across domains where additional symptomatic support is needed to address symptoms that interfere with daily functioning and create noticeable physiological strain.

The medication is commonly used to address the disruptive manifestations of seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (chronic hives). This includes symptom clusters such as frequent sneezing, runny nose, itchy and watery eyes, and recurrent, intense skin itching (pruritus) with associated urticarial welts. The use in this domain contributes to easing the overall symptom load associated with persistent discomfort. Its use is often relevant in settings requiring symptomatic assistance that contributes to functional stability, as the medication offers relief with a non-sedating profile.


Quick Fact: Relief for Key Allergic Symptoms

Property Description
Primary Domain Respiratory and Ocular Allergies (Rhinitis)
Secondary Domain Allergic Skin Conditions (Urticaria)
Functional Benefit Supports symptom management with a non-sedating profile
Use Context Applied during periods of heightened symptoms or seasonal flare-ups

Regulatory References

  1. NIH DailyMed Drug Label
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Telfastin Allergo?

The population eligibility for fexofenadine is strictly defined by regulatory documentation, establishing groups for whom use is permitted, restricted, or prohibited.

Classification Eligibility Status Defined by Regulators
Contraindicated Populations Use is contraindicated for any patient with known hypersensitivity to the active substance, fexofenadine, or any of the inactive ingredients (excipients).
Age-Related Eligibility Standard tablet formulations are approved for adults and adolescents (aged 12 years and over). Safety and efficacy are not established for infants under 6 months of age. Children 6–11 years are eligible for use, typically via lower-dose or suspension formulations.
Organ Function Restrictions Patients with decreased renal function have conditional eligibility, often requiring a dose reduction due to altered drug exposure. The medicine should be administered with care in patients with hepatic impairment and those with a history of cardiovascular disease.
Pregnancy and Lactation Use during pregnancy is not recommended unless the need is clearly essential due to a lack of adequate human data. The medicine is not recommended for mothers who are breastfeeding as fexofenadine is known to pass into breast milk.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for Fexofenadine hydrochloride, the active ingredient in Telfastin Allergo, strictly based on regulatory prescribing information.

Fexofenadine's interaction profile is defined primarily by transporter-mediated effects on systemic exposure, as the drug undergoes only minimal metabolic breakdown.


Documented Exposure-Modifying Interactions

Co-administration with certain products is documented to alter the drug’s plasma concentration:

Interacting Substance Official Outcome (Approximate)
Ketoconazole Increases Fexofenadine Cmax by +135% and AUC by +164%.
Erythromycin Increases Fexofenadine Cmax by +82% and AUC by +109%.
Aluminum/Magnesium Antacids Reduces Fexofenadine Cmax by 43% and AUC by 41%.

Timing and Substance-Based Restrictions

Specific restrictions are required to manage Fexofenadine exposure:

  • Antacids: Co-administration with aluminum and magnesium-containing antacids is documented as should not be taken closely in time due to significantly reduced absorption.
  • Fruit Juices: Juices such as grapefruit, orange, and apple are documented to reduce bioavailability and are restricted. The medication is officially recommended to be taken with water, not fruit juices.
  • Metabolic Interactions: No significant interactions involving the Cytochrome P450 enzyme system are documented.
  • Renal Impairment: Patients with decreased renal function have reduced drug elimination and a significantly longer half-life, resulting in greater peak plasma levels.
Advertisements

Mechanism of Action

Molecular Blockade of Histamine mathbfH1 Receptors

The drug's core action is the selective antagonism (blocking) of the Histamine mathbfH1 receptor (H1R), a primary molecular target on peripheral cells. By binding to the receptor, the molecule prevents endogenous histamine from initiating the rapid molecular cascade that drives mathbfH1-mediated physiological responses.


Modulating Vascular Permeability and Sensory Nerve Signals

Fexofenadine's mechanism directly affects H1R on endothelial cells (capillaries) and peripheral sensory nerves. This molecular blockade results in the maintenance of microvascular integrity, decreasing permeability, and simultaneously interferes with mathbfH1-mediated neural signaling that originates in sensory nerve endings.


Specificity: Restricting Action to Peripheral Systems

A crucial feature of the mechanism is its peripheral specificity, enforced by its use of the P-glycoprotein (P-gp) efflux transporter. This restriction focuses the drug's activity on peripheral physiological systems, thus avoiding modulation of central mathbfH1 receptor pathways.

Advertisements

Dosage and Administration Information

How to Use Telfastin Allergo — Official Administration Guidelines

Telfastin Allergo (fexofenadine hydrochloride) tablets must be taken by oral route with water, adhering to the established dosage and administration guidelines.


Official Dosing and Frequency

Age Group (120 mg/180 mg Tablets) Recommended Dose and Frequency Special Considerations
Adults and Adolescents (12 years and older) 120 mg once daily OR 180 mg once daily. Dose adjustment is generally not necessary for the elderly or for patients with liver impairment.
Children (Under 12 years) Use of 120 mg/180 mg tablets is generally not recommended or the dose must be determined by a healthcare provider. Some formulations (e.g., 30 mg tablets/suspension) have specific rules for children aged 6–11 years (30 mg twice daily).
Renal Impairment A starting dose of 60 mg once daily is recommended for adults with decreased kidney function. Consult a doctor for use in patients with kidney disease as dose adjustment may be necessary.

Administration Requirements

  1. Water Intake and Meals: Tablets should be taken with water. For the 120 mg and 180 mg strengths, administration should occur before a meal.
  2. Fruit Juices: Do not take this medicine with fruit juices, such as grapefruit, apple, or orange juice, as this may reduce its effectiveness.
  3. Antacids: Administration of Telfastin Allergo must be separated from antacids containing aluminum and magnesium hydroxide by approximately two hours.

Missed Dose Instructions

If a dose is missed, skip the forgotten dose and take the next dose at the usual scheduled time. Patients must not take a double dose to compensate for a missed one.

Advertisements

Recent Clinical Evidence

Telfastin Allergo: Recent Clinical Evidence

Evidence for Use in Seasonal Allergic Rhinitis (Hay Fever)

The research base for fexofenadine was studied for seasonal allergic rhinitis, and includes multiple systematic reviews and meta-analyses that combine data from numerous short-term, randomized, placebo-controlled clinical trials. These studies were used in research exploring how symptoms change over time during periods of heightened symptom activity. Researchers examined various outcomes related to physical discomfort, focusing on Total Symptom Scores (TSS). These scores describe symptom intensity for both nasal and ocular symptoms. The findings describe patterns observed when the medication was compared against a control substance. While the evidence describes findings related to symptom patterns, long-term effects are not fully established. The primary data often come from studies with limited follow-up durations, typically lasting two weeks.

Evidence for Use in Chronic Idiopathic Urticaria (Chronic Hives)

Fexofenadine was studied for chronic idiopathic urticaria (CIU), which involves periods of heightened symptoms like intense itching and hives. The research examined these symptoms through multicenter clinical trials that were randomized and placebo-controlled. The studies focused on patient-reported outcomes describing perceived discomfort, evaluating changes in Health-Related Quality of Life (HRQL) and functional outcomes reflecting daily functioning, such as interference with sleep. Research highlights changes measured during the short-to-intermediate-term treatment periods, which were often four to six weeks.

Evidence in Special Populations and Uncertainty

Research has explored the use of fexofenadine in different age groups, including adults, adolescents, and children (as young as 5 or 6 years old). Results apply only to the populations studied, and evidence quality varies across studies, particularly between adults and younger children. Data for certain groups, specifically children below the age of 6, remain insufficient. Furthermore, the evidence base is primarily constructed from trials focusing on episodic changes, and long-term effects are not fully established from the core research used for initial approval. Evidence is limited for the course of symptoms over many months or years of continued use.

Key Studies & References

  1. FEXOFENADINE HCL tablet, film coated - DailyMed (Official US Drug Label)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Telfastin Allergo (FAQ)

Q: How quickly does Telfastin Allergo generally start working?

A: Fexofenadine, the active ingredient, is characterized by rapid absorption. According to the official drug monograph, the onset of action, or when the medicine begins to work, is generally reported to occur within 1 to 3 hours after taking a dose.

Q: How long do the effects of Telfastin Allergo last?

A: Official product information indicates that fexofenadine has a relatively long duration of action. The effects of a single dose are reported to last for approximately 24 hours, and this factor is often associated with a once-daily dosing regimen.

Q: What is the difference between Telfastin Allergo and other common allergy tablets?

A: Telfastin Allergo is classified as a second-generation antihistamine. Regulatory and research documents note that it is designed to be highly selective, which helps to minimize the sedative side effects and anticholinergic effects that are often associated with older, first-generation allergy medicines.

Q: Does Telfastin Allergo affect driving or operating machinery?

A: Though the medicine is classified as non-sedating, side effects like drowsiness and dizziness have been officially reported in clinical data. Official regulatory warnings suggest that individuals should assess their personal response to the medicine before driving or operating machinery.

Q: Are there any long-term risks associated with taking Telfastin Allergo regularly?

A: The safety profile for fexofenadine is based on years of clinical and post-marketing experience. However, official clinical trials used for approval primarily focus on short-term relief. As a result, the data for long-term effects over many months of continued, regular use are not fully established in the core research.

Q: Is it safe to take Telfastin Allergo every day for seasonal allergies?

A: Official regulatory documents indicate that fexofenadine is intended for the daily relief of seasonal allergic rhinitis symptoms, and the typical recommended dosing is once daily. However, it is important to remember that most regulatory research demonstrating efficacy focuses on short-term use.

Q: Is Telfastin Allergo available in liquid or syrup form?

A: Yes, fexofenadine, the active substance, is made available in multiple physical forms to suit different needs. In addition to tablets, official drug information confirms that it can be found as an oral suspension (liquid) and in orally dissolving tablets (ODT).

Q: Does Telfastin Allergo contain lactose or gluten?

A: The inclusion of excipients like lactose or gluten can vary depending on the specific product formulation. Official drug labeling indicates that certain fexofenadine tablet formulations do not contain lactose, while some capsule formulations have been documented to contain it. Information on gluten presence also varies by specific product.

Q: Can Telfastin Allergo be taken with cold or flu medicine?

A: Official regulatory databases list specific interactions with certain antibiotics and antacids. When considering cold or flu medicine, it is important to check the ingredients as many can contain substances that may cause drowsiness or dry mouth, which might potentially increase side effects when combined with fexofenadine.

Q: Does alcohol interact with Telfastin Allergo?

A: Regulatory safety information indicates that fexofenadine does not appear to increase the effects of alcohol. While official safety information suggests avoiding excessive alcohol consumption, any potential increase in sleepiness should be considered.

Q: Is it possible for Telfastin Allergo to affect blood pressure?

A: Fexofenadine on its own is not typically listed as a medicine that affects blood pressure. However, it is important to note that fixed-combination products containing fexofenadine plus a decongestant are often contraindicated (not recommended) for people with severe high blood pressure.

Q: Is there a risk of addiction or dependence with Telfastin Allergo?

A: Regulatory reviews of safety databases, including submissions to the FDA, have indicated no reported cases of drug abuse or dependence associated with fexofenadine.

Q: Is Telfastin Allergo available over-the-counter or by prescription only?

A: Official reports indicate that fexofenadine is commonly available as an over-the-counter (OTC) medicine in many countries. However, the regulatory status—specifically the maximum strength or package size available without a prescription—can differ by geographical region.

Q: Is Telfastin Allergo used for perennial (year-round) allergies?

A: Yes, according to official drug indications, fexofenadine is authorized for the relief of symptoms associated with both seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis (meaning allergies that occur year-round).

Q: Does Telfastin Allergo help with nasal congestion?

A: The fexofenadine active ingredient alone is primarily indicated to relieve symptoms like sneezing, runny nose, and itching. To address significant nasal congestion, the drug is frequently made available in a fixed-dose combination product that includes a decongestant.

Q: Is there any research on the use of Telfastin Allergo for pet allergies?

A: The drug is officially indicated for relieving the overall symptoms of allergic rhinitis, which is triggered by inhaled substances, including pet dander. Regulatory indications cover the allergic condition itself rather than specifying the exact type of allergen source.

Q: Can Telfastin Allergo be used to treat non-allergic conditions?

A: Fexofenadine is indicated only for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria (hives). Regulatory indications for use do not include treatment for conditions that are not allergic in nature.

Q: What is the difference between Telfastin Allergo and the generic version of the drug?

A: The generic version contains the same active ingredient, Fexofenadine hydrochloride, and must meet the same strict quality and safety standards as the branded product. Regulatory bodies require that generic products demonstrate bioequivalence, meaning they act in the body in the same way as the original.

Q: Can Telfastin Allergo affect the results of an allergy skin test?

A: Official warnings note that fexofenadine may interfere with the cutaneous histamine response to allergen extracts, which could affect the results of an allergy skin test. Regulatory advice generally indicates that the medicine may need to be stopped several days before the test.

Q: Does Telfastin Allergo cause dry mouth?

A: While dry mouth is a known possible side effect of antihistamines, fexofenadine is classified as having minimal anticholinergic effects, meaning it is less likely to cause this issue than older medicines. The official safety data, however, indicates that this effect is still possible, though typically uncommon.

Q: Is Telfastin Allergo known to cause weight gain?

A: The official regulatory tables of adverse events for fexofenadine do not commonly list weight gain as a reported side effect. Some general published research has explored a potential link between the use of H1 antihistamines and factors related to weight, but this is not an official warning for this drug.

Q: Are there any reported interactions between Telfastin Allergo and vitamin supplements?

A: Regulatory drug interaction databases generally have not noted specific or major interactions between fexofenadine and most common vitamin supplements. However, it is appropriate to discuss all supplements with a health professional.

Q: Can Telfastin Allergo be taken with pain relievers like paracetamol or ibuprofen?

A: According to regulatory drug interaction screening, no major or moderate interactions have been widely reported between fexofenadine and common over-the-counter pain relievers such as paracetamol (acetaminophen) or ibuprofen.

Advertisements

How should Telfastin Allergo be stored and disposed of?

Storage and Disposal Requirements for Telfastin Allergo

The official requirements for storing and disposing of Telfastin Allergo (fexofenadine hydrochloride) focus on maintaining the product’s stability and ensuring proper environmental handling of waste.

Storage Constraints

The medicine generally does not require any special temperature storage conditions; however, some regulations specify storage at controlled room temperature (20 C to 25 C). The product must be stored in its original package (blister packs) to protect it from moisture and preserve the 3-year shelf-life.

Storage Requirement Rule
Temperature Controlled Room Temperature or no special condition
Packaging Must be kept in the original container
Stability Do not use after the expiry date
Child Safety Keep out of the sight and reach of children

Disposal Instructions

Expired or unused Telfastin Allergo must not be disposed of via wastewater or household trash. To comply with environmental protection rules, the official instruction is to consult a pharmacist regarding the proper process for discarding medicines you no longer need.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Telfastin Allergo found in:

A-Z Index: